AVTXVSGOSS• 28 Days (Normalized)
AVTX vs GOSS (Avalo Therapeutics Inc. vs Gossamer Bio Inc.)
Showing Closing Date Range from Aug, 17 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVTX Performance $16.18
-18.9%
Avalo Therapeutics Inc.
Normalized Baseline0.00%
GOSS Performance $10.7
+7542.86%
Gossamer Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
-7561.76%
GOSS outperforming by 7561.76%
AVTXGOSS
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVTX GOSS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | AVTX Price | AVTX Gain (%) | GOSS Price | GOSS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $16.18 | -18.90% | $10.70 | +7542.86% | -7561.76% |
| Sep 11, 2026 | $16.12 | -19.20% | $10.73 | +7564.29% | -7583.49% |
| Sep 10, 2026 | $17.18 | -13.88% | $11.36 | +8014.29% | -8028.17% |
| Sep 09, 2026 | $18.21 | -8.72% | $12.80 | +9042.86% | -9051.58% |
| Sep 08, 2026 | $19.71 | -1.20% | $14.40 | +10185.71% | -10186.91% |
| Sep 04, 2026 | $19.23 | -3.61% | $14.00 | +9900.00% | -9903.61% |
| Sep 03, 2026 | $19.00 | -4.76% | $14.05 | +9934.29% | -9939.05% |
| Sep 02, 2026 | $19.34 | -3.06% | $0.17 | +23.57% | -26.63% |
| Sep 01, 2026 | $18.95 | -5.01% | $0.17 | +19.29% | -24.30% |
| Aug 31, 2026 | $19.34 | -3.06% | $0.17 | +21.43% | -24.49% |
| Aug 28, 2026 | $19.59 | -1.80% | $0.17 | +21.43% | -23.23% |
| Aug 27, 2026 | $20.05 | +0.50% | $0.17 | +21.43% | -20.93% |
| Aug 26, 2026 | $20.55 | +3.01% | $0.17 | +24.29% | -21.28% |
| Aug 25, 2026 | $19.74 | -1.05% | $0.21 | +46.43% | -47.48% |
| Aug 24, 2026 | $19.27 | -3.41% | $0.18 | +25.00% | -28.41% |
Page 1 of 2